We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+10.59%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$107M
AUM Growth
+$8.23M
Cap. Flow
+$810K
Cap. Flow %
0.76%
Top 10 Hldgs %
41.98%
Holding
67
New
2
Increased
35
Reduced
16
Closed
8
Avg Time Held
12.4 quarters
Top 10 Avg Time Held
3.5 quarters
Top 20 Avg Time Held
8.8 quarters

Top Buys

Rank Stock Value
1
HDP
Hortonworks, Inc.
HDP
+$3.68M
2
CY
Cypress Semiconductor
CY
+$1.65M
3
KTWO icon
K2M Group Holdings, Inc
KTWO
+$1.45M
4
IMPV
Imperva, Inc.
IMPV
+$1.44M
5
IDTI
Integrated Device Technology I
IDTI
+$620K

Top Sells

Rank Stock Value
1
CALD
Callidus Software, Inc.
CALD
+$3.38M
2
SWKS icon
Skyworks Solutions
SWKS
+$2.43M
3
GTLS icon
Chart Industries
GTLS
+$2.04M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$812K
5
ENZ icon
Enzo Biochem, Inc.
ENZ
+$792K

Sector Composition

Rank Sector Weight
1 Healthcare 46.85%
2 Technology 36.6%
3 Financials 3.52%
4 Miscellaneous 2.91%
5 Consumer Discretionary 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
XENT
1
DELISTED
Intersect ENT, Inc
XENT
$7.17M 6.72%
191,382
-5,394
-3% -$212K
2015 Q1
13 quarters
NEO icon
2
NeoGenomics
NEO
$2.07B
$5.73M 5.37%
436,972
+39,495
+10% +$435K
2013 Q2
20 quarters
LGND icon
3
Ligand Pharmaceuticals
LGND
$6.08B
$4.79M 4.5%
37,087
+2,775
+8% +$310K
2013 Q2
20 quarters
IDTI
4
DELISTED
Integrated Device Technology I
IDTI
$4.05M 3.8%
127,211
+19,501
+18% +$620K
2013 Q2
20 quarters
SRGA
5
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$3.99M 3.75%
28,935
-442
-2% -$60.8K
2013 Q2
20 quarters
TWLO icon
6
Twilio
TWLO
$42.8B
$3.87M 3.63%
69,125
+1,240
+2% +$61.4K
2017 Q4
2 quarters
CVLT icon
7
Commault Systems
CVLT
$6.49B
$3.87M 3.63%
58,696
+8,036
+16% +$553K
2014 Q2
16 quarters
CY
8
DELISTED
Cypress Semiconductor
CY
$3.83M 3.59%
245,484
+99,953
+69% +$1.65M
2018 Q1
1 quarter
HDP
9
DELISTED
Hortonworks, Inc.
HDP
$3.73M 3.5%
+204,980
New +$3.68M
2018 Q2
0 quarters
IMPV
10
DELISTED
Imperva, Inc.
IMPV
$3.71M 3.49%
76,995
+30,034
+64% +$1.44M
2016 Q4
6 quarters
ATRC icon
11
AtriCure
ATRC
$2.85B
$3.69M 3.46%
136,463
+9,617
+8% +$226K
2013 Q2
20 quarters
OMCL icon
12
Omnicell
OMCL
$1.68B
$3.62M 3.4%
69,077
+1,757
+3% +$82.6K
2013 Q2
20 quarters
PODD icon
13
Insulet
PODD
$9.56B
$3.38M 3.17%
39,409
-1,742
-4% -$156K
2014 Q2
16 quarters
CYBR icon
14
DELISTED
CyberArk
CYBR
$3.15M 2.96%
50,104
+8,069
+19% +$471K
2016 Q4
6 quarters
OCLR
15
DELISTED
Oclaro Inc.
OCLR
$3.15M 2.96%
352,990
+34,095
+11% +$298K
2013 Q2
20 quarters
KTWO icon
16
DELISTED
K2M Group Holdings, Inc
KTWO
$2.91M 2.73%
129,475
+68,661
+113% +$1.45M
2015 Q3
11 quarters
NXTM
17
DELISTED
NxStage Medical Inc.
NXTM
$2.91M 2.73%
104,360
+10,472
+11% +$281K
2013 Q4
18 quarters
EGHT icon
18
8x8 Inc
EGHT
$295M
$2.81M 2.63%
140,064
-1,443
-1% -$28.8K
2016 Q2
8 quarters
TLGT
19
DELISTED
Teligent, Inc
TLGT
$2.65M 2.49%
76,630
-21,194
-22% -$667K
2014 Q1
17 quarters
FNSR
20
DELISTED
Finisar Corp
FNSR
$2.58M 2.42%
143,273
+21,765
+18% +$360K
2013 Q2
20 quarters
SUPN icon
21
Supernus Pharmaceuticals
SUPN
$2.47B
$2.51M 2.35%
41,879
+4,903
+13% +$254K
2016 Q2
8 quarters
VCEL icon
22
Vericel Corp
VCEL
$2.06B
$2.49M 2.34%
256,657
-2,570
-1% -$32K
2017 Q1
5 quarters
MXL icon
23
MaxLinear
MXL
$8.18B
$2.09M 1.96%
134,268
+21,356
+19% +$431K
2014 Q3
15 quarters
HZNP
24
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.54M 1.45%
93,220
-7,807
-8% -$119K
2017 Q2
4 quarters
AAPL icon
25
Apple
AAPL
$4.96T
$1.39M 1.31%
30,092
+1,096
+4% +$49.7K
2016 Q3
7 quarters
1
2 3

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Kopp Investment Advisors held 67 positions worth $107M, up 8.4% from $98.4M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Kopp Investment Advisors's Q2 2018 filing shows 2 new, 35 increased, 16 reduced and 8 closed positions. Its largest new stake was Hortonworks, Inc.: 204,980 shares worth $3.73M. The largest sale was Callidus Software, Inc., an estimated $3.38M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Technology and Financials.

  • Kopp Investment Advisors's largest Q2 2018 buy was Hortonworks, Inc.: 204,980 shares worth $3.73M.
  • Kopp Investment Advisors added most to Cypress Semiconductor in Q2 2018, an estimated $1.65M increase.
  • Kopp Investment Advisors's biggest Q2 2018 reduction was Enzo Biochem, Inc., cutting an estimated $792K.
  • Kopp Investment Advisors fully exited Callidus Software, Inc. in Q2 2018, selling an estimated $3.38M.
  • Kopp Investment Advisors's ten largest holdings make up 42% of its $107M portfolio in Q2 2018.
  • Kopp Investment Advisors opened 2 new positions and closed 8 in Q2 2018.
  • Kopp Investment Advisors's portfolio value rose 8.4% quarter-over-quarter to $107M.

Based on Kopp Investment Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.